EasySep™小鼠TIL（CD45）正选试剂盒
产品号 #05513_C
用于培养小鼠MSCs和MEFs
若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系
You may notice that your reagent packaging looks slightly different from images displayed here or from previous orders. Due to pandemic-related plasticware shortages, we are temporarily using alternative bottles for this product. Rest assured that the products themselves and how you should use them have not changed.
专为您的实验方案打造的产品
要查看实验方案所需的所有配套产品，请参阅《实验方案与技术文档》。
-
3% Acetic Acid with Methylene BlueReagent for manual counting of nucleated mammalian cells
-
L-GlutamineCell culture supplement
-
Trypsin-EDTA (0.25%)Enzymatic cell dissociation reagent
-
EasySep™ BufferCell separation buffer
总览
MesenCult™ 扩增试剂盒 (小鼠）是标准的用于小鼠间充质间质细胞（MSCs，也称为间充质干细胞)和小鼠胚胎成纤维细胞（MEFs）培养的培养基。该试剂盒包括MesenCult™基础培养基（小鼠），MesenCult™10X补充剂（小鼠）和MesenPure™。MesenCult™扩增培养基已经过优化，可用于小鼠MSCs和MEFs的衍生和体外扩增，以及用于成纤维细胞集落形成单位（CFUF）的检测。该试剂盒使用小鼠品系C57BL/6的细胞进行优化。
为了促进MSCs和MEFs在细胞培养过程中的富集，只需在使用前添加MesenPure™以配置MesenCult™扩增完全培养基，而无需通过连续传代和频繁的培养基换液。虽然不是必需的，但强烈建议添加MesenPure™，因为与单独使用Mesenult™扩增完全培养基相比，所得到的MSC和MEF培养物更均质，并且表现出更强大的增殖、分化和集落形成能力。
注意：MesenCult™ 扩增培养基必须补充L-谷氨酰胺（产品号 #07100）。
为了促进MSCs和MEFs在细胞培养过程中的富集，只需在使用前添加MesenPure™以配置MesenCult™扩增完全培养基，而无需通过连续传代和频繁的培养基换液。虽然不是必需的，但强烈建议添加MesenPure™，因为与单独使用Mesenult™扩增完全培养基相比，所得到的MSC和MEF培养物更均质，并且表现出更强大的增殖、分化和集落形成能力。
注意：MesenCult™ 扩增培养基必须补充L-谷氨酰胺（产品号 #07100）。
为了促进MSCs和MEFs在细胞培养过程中的富集，只需在使用前添加MesenPure™以配置MesenCult™扩增完全培养基，而无需通过连续传代和频繁的培养基换液。虽然不是必需的，但强烈建议添加MesenPure™，因为与单独使用Mesenult™扩增完全培养基相比，所得到的MSC和MEF培养物更均质，并且表现出更强大的增殖、分化和集落形成能力。
注意：MesenCult™ 扩增培养基必须补充L-谷氨酰胺（产品号 #07100）。
为了促进MSCs和MEFs在细胞培养过程中的富集，只需在使用前添加MesenPure™以配置MesenCult™扩增完全培养基，而无需通过连续传代和频繁的培养基换液。虽然不是必需的，但强烈建议添加MesenPure™，因为与单独使用Mesenult™扩增完全培养基相比，所得到的MSC和MEF培养物更均质，并且表现出更强大的增殖、分化和集落形成能力。
注意：MesenCult™ 扩增培养基必须补充L-谷氨酰胺（产品号 #07100）。
亚型
专用培养基
细胞类型
间充质干/祖细胞，鼠胚胎成纤维细胞
种属
小鼠
应用
细胞培养，克隆筛选，扩增
品牌
MesenCult
研究领域
干细胞生物学
实验数据
产品说明书及文档
请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。
应用领域
本产品专为以下研究领域设计，适用于工作流程中的高亮阶段。探索这些工作流程，了解更多我们为各研究领域提供的其他配套产品。
相关材料与文献
技术资料 (5)
文献 (16)
Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell stem cell 2021 feb
Abstract
Skeletal aging is a complex process, characterized by a decrease in bone formation, an increase in marrow fat, and stem cell exhaustion. Loss of H3K9me3, a heterochromatin mark, has been proposed to be associated with aging. Here, we report that loss of KDM4B in mesenchymal stromal cells (MSCs) exacerbated skeletal aging and osteoporosis by reducing bone formation and increasing marrow adiposity via increasing H3K9me3. KDM4B epigenetically coordinated $\beta$-catenin/Smad1-mediated transcription by removing repressive H3K9me3. Importantly, KDM4B ablation impaired MSC self-renewal and promoted MSC exhaustion by inducing senescence-associated heterochromatin foci formation, providing a mechanistic explanation for stem cell exhaustion with aging. Moreover, while KDM4B was required for parathyroid hormone-mediated bone anabolism, KDM4B depletion accelerated bone loss and marrow adiposity induced by a high-fat diet. Our results suggest that the epigenetic rejuvenation and reversing bone-fat imbalance might be new strategies for preventing and treating skeletal aging and osteoporosis by activating KDM4B in MSCs.
Aging-Related Reduced Expression of CXCR4 on Bone Marrow Mesenchymal Stromal Cells Contributes to Hematopoietic Stem and Progenitor Cell Defects. Stem cell reviews and reports 2020 may
Abstract
Aging impairs the regenerative potential of hematopoietic stem cells (HSC) and skews differentiation towards the myeloid lineage. The bone marrow (BM) microenvironment has recently been suggested to influence HSC aging, however the mechanisms whereby BM stromal cells mediate this effect is unknown. Here we show that aging-associated decreased expression of CXCR4 expression on BM mesenchymal stem cells (MSC) plays a crucial role in the development of the hematopoietic stem and progenitor cells (HSPC) aging phenotype. The BM MSC from old mice was sufficient to drive a premature aging phenotype of young HSPC when cultured together ex vivo. The impaired ability of old MSC to support HSPC function is associated with reduced expression of CXCR4 on BM MSC of old mice. Deletion of the CXCR4 gene in young MSC accelerates an aging phenotype in these cells characterized by increased production of reactive oxygen species (ROS), DNA damage, senescence, and reduced proliferation. Culture of HSPC from young mice with CXCR4 deficient MSC also from young mice led to a premature aging phenotype in the young HSPC, as evidenced by reduced hematopoietic regeneration and enhanced myeloid differentiation. Mechanistically, CXCR4 signaling prevents BM MSC dysfunction by suppressing oxidative stress, as treatment of old or CXCR4 deficient MSC with N-acetyl-L-cysteine (NAC), improved their niche supporting activity, and attenuated the HSPC aging phenotype. Our studies suggest that age-associated reduction in CXCR4 expression on BM MSC impairs hematopoietic niche activity with increased ROS production, driving an HSC aging phenotype. Thus, modulation of the SDF-1/CXCR4 axis in MSC may lead to novel interventions to alleviate the age-associated decline in immune/hematopoietic function.
Increased yield of gelatin coated therapeutic cells through cholesterol insertion. Journal of biomedical materials research. Part A 2020 jun
Abstract
Gelatin coatings are effective in increasing the retention of MSCs injected into the heart and minimizing the damage from acute myocardial infarction (AMI), but early studies suffered from low fractions of the MSCs coated with gelatin. Biotinylation of the MSC surface is a critical first step in the gelatin coating process, and in this study, we evaluated the use of biotinylated cholesterol lipid insertion" anchors as a substitute for the covalent NHS-biotin anchors to the cell surface. Streptavidin-eosin molecules where eosin is our photoinitiator can then be bound to the cell surface through biotin-streptavidin affinity. The use of cholesterol anchors increased streptavidin density on the surface of MSCs further driving polymerization and allowing for an increased fraction of MSCs coated with gelatin (83{\%}) when compared to NHS-biotin (52{\%}). Additionally the cholesterol anchors increased the uniformity of the coating on the MSC surface and supported greater numbers of coated MSCs even when the streptavidin density was slightly lower than that of an NHS-biotin anchoring strategy. Critically this improvement in gelatin coating efficiency did not impact cytokine secretion and other critical MSC functions. Proper selection of the cholesterol anchor and the biotinylation conditions supports cellular function and densities of streptavidin on the MSC surface of up to {\~{}}105 streptavidin molecules/$\mu$m2 . In all these cholesterol anchors offer an effective path towards the formation of conformal coatings on the majority of MSCs to improve the retention of MSCs in the heart following AMI."
更多信息
| 种属 | Mouse |
|---|
相关产品
-
MesenCult™ 成骨刺激试剂盒（小鼠）小鼠间充质干细胞和胚胎成纤维细胞分化为成骨细胞的完全培养基
-
缺氧小室培养室为组织培养提供缺氧环境
-
D-PBS无钙无镁平衡盐溶液杜氏磷酸盐缓冲液，不含钙和镁离子
-
Falcon®锥形管，50 mL用于细胞分离和细胞培养的无菌聚丙烯锥形管
